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A B S T R A C T
In this work, the Supercritical AntiSolvent (SAS) process has been used to generate micronized crystals of
Sulfathiazole (STZ) from different organic solutions, namely acetone, acetonitrile, tetrahydrofuran and acetic
acid. The flow rates of CO2 (2–21 g min−1) and of the organic solution (0.19–6 mL min−1), as well as STZ
concentration in the organic solution (20–70% under the saturation), have been varied to identify the conditions
leading to powders exhibiting only one polymorphic form. Pressure (10 MPa) and temperature (313 K) have
been kept constant. In this paper, thermodynamic and hydrodynamic aspects are discussed so as to rationalize
the obtained crystal characteristics and provide a new way to control the SAS process applied to drug pre-
formulation. The influence of the organic solvent nature on both the polymorphic form and the habit of gen-
erated crystals, has been particularly discussed.
1. Introduction
Crystallization processes involving a supercritical medium are
gaining momentum as they are regarded as environmentally friendly
processes and allow good control over product properties, especially
particle size, Particle Size Distribution (PSD), crystal habit and poly-
morphic form. This is mainly because crystallization processes using sc-
CO2 often involve only one crystallization step, unlike conventional
methods of crystallization in solution. CO2 being gaseous at ambient
conditions of pressure and temperature, the separation of CO2 from the
end-products is spontaneous and does not require successive separation
operations. Thus, a single-step process or a process involving a reduced
number of steps will lead to the formation of powders with homo-
geneous characteristics. When a series of steps is involved, the size as
well as the habit or the polymorphic nature of the crystals may evolve.
The good control of powder characteristics using supercritical fluids is
also due to the large number of operating parameters and conditions
(pressure, temperature, hydrodynamics and mixing conditions, super-
saturation level, etc.) that can extensively be varied, therefore allowing
efficient screenings for particle drug design. Amongst the different
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supercritical processes, the Supercritical AntiSolvent (SAS) process,
using supercritical carbon dioxide (sc-CO2) as crystallization anti-
solvent, brings particular interest for drug reprocessing [1–9], that are
often sparingly soluble into sc-CO2.
Crystallization during the SAS process is both induced by the sc-CO2
antisolvent effect and by the organic solvent depletion. When the or-
ganic solution containing the solute to recrystallize and sc-CO2 are put
in contact, the organic solvent diffuses into the CO2-rich phase while
CO2 diffuses into the organic solution-rich phase, quickly leading to
solute supersaturation in the organic solution’s expanded phase. Crystal
size is often at the micron or sub-micron order of magnitude thanks to
the rapid transfer phenomena in supercritical media, which represents
one of the most important assets of this technology.
This paper presents an experimental application of drug reproces-
sing by SAS, using Sulfathiazole (STZ) as the solute to be recrystallized.
This compound, a veterinary drug, has a complex drug behavior re-
garding its ability to crystallize into five known polymorphic forms
[10]. For that criterion, it has been widely described in literature either
for crystallographic investigations [11–15] or for crystallization beha-
vior into both liquid phases [16,17] or supercritical media [18–20]. It is
worth noting that different nomenclatures exist for the five poly-
morphic forms of Sulfathiazole. In this study, the nomenclature pro-
posed by Apperley et al. has been adopted [13]. A brief description of
the five crystal cells and their Cambridge Structural Database (CSD) re-
ference are given in Table 1.
Two forms are commonly observed throughout experimentations,
namely so-called forms I and IV. At ambient conditions, the relative
stability is IV > I. Furthermore, Munroe et al. [21] investigated the
relative stabilities of the five polymorphs of Sulfathiazole depending on
the temperature. It appears that, from 283 K up to 323 K at atmospheric
pressure, polymorphic form I is the least stable of all five forms, then
this order follows: I < II < V < IV < III.
Commonly, process development around drug particle generation
consists in optimizing the drug bioavailability by reducing its size,
narrowing its size distribution and controlling both crystal habit and
polymorphism. As mentioned above, the SAS process can be tuned to
target given specific properties of the end-product. Temperature, pres-
sure, solute concentration in the feeding solution and flow rates of both
CO2 and organic solution phases are commonly screened parameters
[22]. Erriguible et al. [23] proposed a complete 3D simulation of the
SAS process by varying operating conditions in a range of typical target
conditions. They have investigated the crystallization of a solution of
minococycline-ethanol and predicted a reduction of particle size by
decreasing the solid-fluid interfacial tension as well as by increasing the
initial concentration in the feeding solution or by increasing the in-
jection jet velocity. Estimation of the interfacial tension has been re-
ported as of major interest to consider the simulation as a predictive
tool. Jet dispersion conditions of the organic solution were reported as a
significant criterion to control particle characteristics by Petit-Gas et al.
[24]. They have studied the crystallization of a solution of STZ-acetone
in SCeCO2. Finer particles of STZ were obtained for higher jet velo-
cities, but also with larger capillary internal diameter at a constant jet
velocity. Furthermore, different morphologies were observed, corre-
sponding to different polymorphic forms of STZ crystals, for different
Reynolds number values of the organic solution. Careno et al. [25] and
Boutin et al. [26] studied alternative injection technology, namely
impinging jets and concentric tubes, to greatly enhance phase mixing
and mass transfers, thus reducing crystal size, for STZ-acetone and STZ-
methanol systems. Other enhanced mass transfer conditions were suc-
cessfully achieved for the SAS process, by atomizing the liquid jet on a
vibrating surface at an ultrasonic frequency [27] (Griseofulvin-di-
chloromethane and Griseofulvin-tetrahydrofuran systems) or by stirring
[28] (Griseofulvin-acetone system). As for conventional recrystalliza-
tion methods in solution, the organic solvent nature has also been re-
ported as one of the most significant factors that control the SAS process
and crystal habit. It has been proven that changing the organic solvent
[29,30], or adding a growth inhibitor [31], may modify the crystal
habit without modifying its crystal structure. A probable explanation is
that the growth of one crystal’s face may be selectively slowed down in
comparison to the others due to solvent–or growth inhibitor–adsorp-
tion, which depends on the interaction between the solvent molecules
and the solute molecules on crystal faces.
However, predicting and controlling the polymorphic form of the
solute crystals has been less extensively studied. Kordikowski et al. [32]
showed in the case of STZ recrystallized from acetone, that the flow
ratio (CO2/acetone) has a preponderant role influencing the poly-
morphic form, whilst temperature has a preponderant role in the case of
STZ reprocessed from methanol. The polymorphic form of STZ has
therefore been related to the choice of solvent. Bouchard et al. [33]
highlighted a strong dependence of glycine polymorphic form behavior
on both the solute concentration into the feed and the ethanol fraction
in the CO2-rich phase. The form IV is obtained for higher solute con-
centration and lower ethanol fraction, thus for higher supersaturation
values. Later, Rossmann et al. [34] investigated the case of paracetamol,
concluding that varying the solvent nature, in this case acetone, ethanol
and a mixture of both, can lead to a modification of the crystalline form.
In this work, SAS process experiments were carried out at constant
temperature (313 K) and pressure (10 MPa), but organic solution and
sc-CO2 flow rates, STZ concentration and organic solvent nature were
varied with the aim of obtaining powders exhibiting only one poly-
morphic form. Thirteen solvents exhibiting different polarity and pro-
ticity properties were tested in a preliminary solubility measurement
study at ambient pressure. Among them, four were retained for the SAS
experiments according to their solvent power regarding STZ: acetone,
acetonitrile, tetrahydrofuran and acetic acid. Solubility measurements
of STZ in the four selected organic solvents were performed to evaluate
the saturation degree of the initial organic solution used for the SAS
process. The powders were characterized by 13C Nuclear Magnetic
Resonance (NMR) to determine the nature of the polymorphic forms
obtained pure or in mixture. Pure crystalline powders in terms of
polymorphic form were also observed by Scanning Electron Microscopy
(SEM). Crystal characteristics were then discussed by considering the
varied operating conditions corresponding to different thermodynamic
and kinetic conditions.
2. Materials and methods
2.1. Materials
STZ (polymorphic form III), acetone and tetrahydrofuran were
Table 1
Crystal lattice for the five polymorphic forms of Sulfathiazole.
Polymorphic form I II III IV V
CSD Ref. Code SUTHAZ01 SUTHAZ05 SUTHAZ02 SUTHAZ SUTHAZ04
a (Å) 10.554 10.399 17.570 8.235 10.867
b (Å) 13.220 15.132 8.570 8.550 8.543
c (Å) 17.050 14.280 15.583 15.580 11.456
β (deg) 108.06 91.21 112.93 93.67 88.13
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purchased from Sigma-Aldrich, France; Acetonitrile was purchased
from VWR; Acetic acid was purchased from Fisher, France. All chemi-
cals were purchased at purity > 98% and were used without further
purifications. Carbon dioxide (purity of 99.7%) was purchased from Air
Liquide, France.
2.2. Solubility measurements procedure
STZ and organic solvent are mixed together with a magnetic stir bar
in a sealed container with an intentional excess of solute. The container
is placed in a temperature bath regulated at 313 K. After several hours,
the agitation is stopped and a part of the supernatant is collected with a
syringe equipped by a millipore filter (VWR −0.45 μm). This sample is
immediately diluted in a weighed quantity of pure solvent to prevent
the crystallization from occurring through cooling. The concentration
of the diluted solution is given by density measurement, referred to a
calibration curve, with a density meter DMA 5000 M Anton (precision
of 10−6 g cm−3), at 293 K.
2.3. Experimental set-up for SAS process
The experimental apparatus used for this study is detailed in Fig. 1.
It includes a 480 mL (internal diameter: 60 mm) double jacket auto-
clave (TOP INDUSTRIE, France). The maximum allowable pressure is
25 MPa at a temperature of 423 K. It is equipped with pressure and
temperature sensors, as well as an 18 MPa rupture disk. The fluids,
namely CO2 and organic solution, are injected at the top of the auto-
clave thanks to two high pressure liquid piston pumps (SEPAREX,
France and GILSON, France, respectively for CO2 and organic solution).
Organic solution feed is injected through a 127 μm internal diameter
capillary tube. CO2 flow is measured thanks to a Coriolis Effect flow-
meter (BRONKHORST, France). A frit filter (2 μm) and a glass fiber
filter (1.2 μm) are placed at the bottom of the autoclave to retain and
easily collect generated particles. A cold solvent trap allows the se-
paration of exiting fluids: CO2 is evacuated and organic solution is re-
cycled.
2.4. Experimental procedure
A first step consists in stabilizing the composition in the autoclave at
the target conditions by injecting CO2 and pure solvent. The target
pressure and target temperature have been respectively fixed at 10 MPa
and 313 K to ensure monophasic conditions. When the target conditions
are reached, exit valves are open and the operating conditions are
stabilized. Then, pure solvent feed is replaced by the organic solution,
containing the solute to be crystallized. The solute concentration is
given as a fraction of the organic solution saturation at 313 K, noted
βOS.
From that time on, sc-CO2 has an antisolvent role. CO2 and organic
solvent reversediffusion occurs due to concentration gradient, causing a
rapid and large supersaturation, thus a fast crystallization.
The generated particles are retained at the bottom of the autoclave.
At the end of the injection step, the injection line is washed with pure
solvent to avoid nozzle clogging, then the organic solvent flow is
stopped. The CO2 flow is kept so as to renew the fluid phase content in
the autoclave and dry the crystalline powder, from 3 up to 5 residence
time. At the end of these washing steps, the autoclave pressure is
dropped to atmospheric pressure and the powder that has been accu-
mulated on the filter is collected.
The experimental conditions tested in this work are listed in Table 3
(see part 3.2). Feed flows of both phases as well as STZ concentration
into the organic solution were varied to identify which operating con-
ditions allow the formation of pure powders in term of polymorphic
form, for each studied solvent, namely acetone (Acet), acetonitrile
(ACN), tetrahydrofuran (THF) and acetic acid (AcAc). CO2 and organic
solution flow rates were varied from 2 up to 21 gmin−1 and from 0.19
up to 6 mL min−1 respectively. Thus, solvent to CO2 molar ratios (Xsolv/
CO2) were varied from 5 up to 23 mol%.
Fig. 1. Apparatus for crystallization using the SAS
process. E1 to E3: heat exchangers; V1: valve; V2 and
V3: 3-ways valves; V4 and V5: depressurizing valves;
P1 and P2: high pressure liquid piston pumps; D1
and D2: rupture discs, F1: solvent frit filter; F2: glass
fiber filter; S1: cold solvent trap; R1: CO2 pressurized
bottle; R2: organic solution tank; R3: pure solvent
tank; R4: crystallization autoclave.
Table 2
List of solvents used for the solubility measurements at ambient pressure. PA = polar
aprotic; PP = polar protic; NP = non-polar.
Solvent Origin #CAS ε [35] Nature Cs at 313 K
(%w/w)
Ethanol Sigma-
Aldrich
64–17–5 25.30 PP ≈0.75
Propanol-1 Carlo-Erba 71–23–8 20.80 < 0.75
Propanol-2 Carlo-Erba 67–63–0 20.18 < 0.75
Acetic acid Fisher 64–19–7 6.20 0.83
Dimethyl sulfoxide SDS 67–68–5 47.24 PA >10
Acetonitrile VWR 75–05–8 36.64 1.42
N-Methyl-2-
pyrrolidone
Sigma-
Aldrich
872–50– 32.55 > 10
Acetone Sigma-
Aldrich
67–64–1 21.01 3.11
Tetrahydrofuran Sigma-
Aldrich
109–99–9 7.52 1.15
Ethyl acetate Carlo-Erba 141–78–6 6.08 < 0.75
Chloroform Carlo-Erba 67–66–3 4.81 NP <0.75
Diethyl ether SDS 60–29–7 4.27 < 0.75
Limonene Prolabo 138–86–3 2.37 < 0.75
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2.5. Polymorphic form characterization using 13C NMR
Each crystal powder was analyzed to determine the polymorphic
form, or the composition of polymorph mixtures, of generated particles.
X-Ray Diffraction is a commonly encountered method, but can lack
precision when it comes to quantitative analysis. In this work, solid-
state Nuclear Magnetic Resonance was chosen for both the qualitative
and quantitative analysis of STZ powders, using a BRUKER AVANCE III
400 MHz spectrometer, working at a 13C resonance frequency of
106 MHz. Characteristic NMR signals for STZ are taken from Apperley
et al. [13].
2.6. Particle observations by SEM
Generated crystals are observed with a Scanning Electron
Microscope to determine the crystal habit for each observed sample.
Moreover, particle size and the size distributions was determined for
the samples exhibiting only one polymorphic form. SEM observations
were performed thanks to the JEOL JSM 6320-F device, working with a
field emission gun. A metallization step with a gold plasma for 90 s was
performed before each observation.
3. Results and discussions
3.1. Solubility of sulfathiazole into organic solvent
STZ solubility was measured into several solvents considered po-
tentially eligible (either for toxicity or solubility in SCeCO2) to be ap-
plied to the SAS process for recrystallizing active pharmaceutical in-
gredients. A list of every tested solvent is given in Table 2. They vary in
their intrinsic properties of polarity and proticity and are classified
according to their relative permittivity ε. Four solvents were selected,
for which the solubility of STZ is included between 0.75 and 10% in
weight concentration. Solubility lower than 0.75% w/w. is quite low for
a good productivity of the process whereas solubility higher than 10%
w/w. may imply drug solubilization in the supercritical phase during
the SAS process. These four solvents are acetone, acetonitrile, tetra-
hydrofuran and acetic acid. Every other tested solvent doesn’t solubilize
a large enough amount of STZ to be used in this study, except for di-
methyl sulfoxide and N-Methyl-2-pyrrolidone, both solubilizing STZ
over 10%w/w. Logically, only polar solvents allow a good solubility for
STZ, exhibiting a better affinity for aprotic solvents than for protic ones.
Solubility was obtained from calibration curves shown in Fig. 2,
giving the density of the organic solution according to the concentra-
tion of STZ in it. Density measurements were performed at 293 K.
Table 3
Experimental conditions. Acet = Acetone, ACN= acetonitrile, THF = tetrahydrofuran, AcAc = acetic acid.
# Exp. Solvent OS flow rate (mL min−1) CO2 flow rate (g min−1) Rejet ReCO2 βOS (%) Xsolv/CO2 (mol%) Polymorph
1 Acet 4 21 1529 155 60 11 Mixture (I + IV)
2 3.5 21 1338 155 9.6 Mixture (I + IV)
3 3 21 1147 155 8.2 I
4 1.9 21 726 155 5.2 Mixture (I + IV)
5 1.9 21 726 155 40 5.3 Mixture (I + IV)
6 1.9 21 726 155 20 5.3 Mixture (I + IV)
7 1.9 10 726 74 60 11 IV
8 1.9 5 726 37 22 Mixture (I + IV)
9 1.38 15 528 111 5.3 Mixture (I + IV)
10 0.91 10 348 74 5.3 Mixture (I + IV)
11 0.42 5 161 37 4.8 IV
12 0.19 2 73 15 5.5 IV
13 ACN 6 21 2157 155 60 23 Mixture (I + IV)
14 5 21 1797 155 19 Mixture (I + IV)
15 3 21 1078 155 70 11 Mixture (I + IV)
16 2.5 10 899 74 60 20 Mixture (I + IV)
17 2 8 719 59 20 Mixture (I + IV)
18 1.9 21 683 155 70 7.3 I
19 1.9 21 683 155 60 7.3 IV
20 1.9 10 683 74 15 Mixture (I + IV)
21 1.5 8 539 59 15 Mixture (I + IV)
22 1.35 21 485 155 70 5.2 IV
23 1.35 21 485 155 60 5.2 IV
24 1.25 5 449 37 20 Mixture (I + IV)
25 1 8 359 59 10 Mixture (I + IV)
26 0.94 5 338 37 15 Mixture (I + IV)
27 0.63 5 226 37 10 Mixture (I + IV)
28 THF 6 21 2088 155 60 15 Mixture (III + IV)
29 5 21 1797 155 13 Mixture (I + IV)
30 3.8 10 1322 74 20 Mixture (III + IV)
31 3.04 8 1058 59 20 I
32 2.7 10 940 74 14 Mixture (I + IV)
33 2.16 8 752 59 14 Mixture (I + IV)
34 1.9 21 661 155 4.8 IV
35 1.9 10 661 74 10 Mixture (I + IV)
36 1.9 5 661 37 20 Mixture (I + IV)
37 1.52 8 529 59 10 Mixture (I + IV)
38 1.35 21 470 155 3.4 IV
39 1.35 5 470 37 14 Mixture (I + IV)
40 0.95 8 331 59 10 Mixture (I + IV)
41 AcAc 1.9 12 401 89 60 12 I
42 1.17 15 247 111 5.9 I
43 0.31 5 65 37 4.7 I
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3.2. Influence of operating conditions on polymorphic form
The SAS experimental conditions performed during this work are
listed in Table 3. Polymorphic form obtained from solid state NMR are
also reported. 13C NMR spectra are presented in Fig. 3, for powders of
pure form I, pure form IV and a mixture of form I and IV.
For each of the three solvents, Acetone, Acetonitrile and
Tetrahydrofuran, a dozen experiments mainly led to the formation of
powders composed of a mixture of polymorphs (I and IV). Nevertheless,
it is worth noting that for each solvent, pure polymorphic forms (I or
IV) were obtained for given operating conditions. In addition, experi-
ments with acetic acid led exclusively to the formation of pure poly-
morphic form I.
CO2 and organic solution (OS) flow rates as well as STZ con-
centration in the OS were varied to identify operating conditions al-
lowing the formation of powders that exhibit only one polymorphic
form. To interpret the effect of hydrodynamics on the polymorphic
nature of obtained particles, Reynolds numbers describing the flows of
the organic solution jet (Rejet) and of the carbon dioxide into the pre-
cipitation vessel (ReCO2) were calculated as follows:
=Re
ρ u d
μjet
orga jet nozzle
orga (1)
=Re
ρ u d
μCO
CO CO autoclave
CO
2
2 2
2 (2)
Where ρorga and ρCO2 are measured organic solution and carbon dioxide
densities, respectively, ujet is the jet velocity at the exit of the injection
nozzle of a diameter dnozzle of 127 μm, uCO2 is the CO2 velocity
throughout the crystallization vessel (considering only CO2) of a dia-
meter of 60 mm, μorga (measured) and μCO2 [36] are organic solution
and carbon dioxide viscosities, respectively.
The Reynolds numbers associated to both flows correspond to la-
minar flows (Re < 2500) since they vary from 73 to 2157 for the or-
ganic solution flow and from 15 to 155 for the CO2 flow. These values of
Reynolds numbers correspond to different modes of jet dispersion; the
highest values corresponding to atomized jet leading to more intense
mixing conditions.
Furthermore, the characteristic times associated to the different
effects controlling the jet dispersion were calculated [37]. Inertial,
aerodynamic and viscous effects were calculated for each presented
experiment. Inertial and aerodynamic effects are preponderant since
their associated characteristic times, respectively between 16 up to
508 μs and 17 up to 599 μs, are the lowest in comparison with times
associated with the viscous effects (20 up to 37 ms). Inertial effects have
a stabilizing effect on the jet during its dispersion while aerodynamic
effects are destabilizing ones.
It is evidenced that intense mixing conditions, such as for experi-
ments #3, #18, #31 or #41, lead to the formation of pure form I. In this
case, mass transfers are enhanced, and so are the nucleation rates.
Besides, less intense mixing conditions such as for experiments #11,
#12, #22, #23, #34 or #38, lead to the formation of form IV.
Acetic acid used as solvent represents an interesting case, as it only
allows the formation of pure form I, whatever the operating conditions.
It is also the only polar protic solvent used in this study. The presence of
pure form I is observed at every operating condition, at both intense
and moderate mixing conditions. Further investigations are required to
fully interpret this observation. Experiments #41, #42 and #43 are
therefore not considered in the following interpretation.
For experiments that led to pure polymorphic form, the Rejet and
ReCO2 are plotted in Fig. 4. Points obtained from acetic acid were re-
moved.
It shows a clear influence of the Rejet on the obtained form. Amongst
the presented experimental conditions, excluding points from acetic
acid, every pure powder obtained at Rejet ≤ 508 is pure form IV, while
every pure powder obtained at Rejet ≥ 1058 is pure form I. A region
where both pure form I and pure form IV were obtained is observed at
661 ≤ Rejet ≤ 726. It can be noticed that the only pure form I present
in this region was obtained with a higher STZ concentration in the OS
(βOS = 70%, 60% for the other ones). Furthermore, the CO2 flow rate
has no direct influence on the obtained form. Indeed, both pure form I
and IV were obtained at either higher or lower ReCO2 values. Therefore,
the mixing is more dependent on the organic solution flow rate than on
the CO2 flow rate. Obtaining a pure form IV hence has more chance to
Fig. 2. Density calibration curves at 293 K for (a)
acetone, (b) acetonitrile, (c) tetrahydrofuran, (d)
acetic acid.
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occur at lower Rejet, independently of ReCO2.
The Xsolv/CO2 values in which pure forms were obtained are ranged
between 7.3% up to 20% for form I and 3.4% up to 11% for form IV.
There is therefore no evidence that the polymorphic form of a pure
Table 4
Repeatability measurement.
# Exp. Polymorphic form
4 Mixture (I + IV)
4′ Mixture (I + IV)
4” Mixture (I + IV)
12 IV
12′ IV
Fig. 3. NMR spectra for the identification and quantification of form I, form IV and a mixture of form I and IV of STZ. a lines: characteristic picks of form IV at 118.6 ppm and 120.2 ppm;
b lines: characteristic picks of form I at 114.2 ppm and 115.7 ppm.
Fig. 4. Rejet and ReCO2 numbers of conditions that led to pure polymorphic form. Form I
powders were obtained in acetone (■), acetonitrile (▲) and tetrahydrofuran (●); Form
IV powders were obtained in acetone (□), acetonitrile (△) and tetrahydrofuran (○).
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powder is directly dependent on this variable. Indeed, Xsolv/CO2 has a
complex influence on the polymorphic form: as it rises, the solute so-
lubility in the continuous fluid phase increases and, consequently, the
overall supersaturation decreases and the concentration gradient be-
tween the dispersed and the continuous phases decreases. This slows
down the nucleation and growth rate and thus may promote the for-
mation of the most stable form. For example, Kordikowski et al. mea-
sured the STZ molar solubility in both pure and methanol modified
CO2. At 10 MPa and 313 K, it rises from 8.1 × 10−9 in pure CO2 to
1.56 × 10−5 in the modified phase containing Xmethanol/CO2 = 0.1412
[19]. However, the highest values of Xsolv/CO2 are inevitably obtained at
high organic solution flow rates, which promotes the formation of the
less stable form due to more intense mixing conditions.
Solvent nature also has an important influence over the poly-
morphic form for given flow rates of both phases. Indeed, some key
comparisons, for example experiments #4, #19 and #34 together, or
experiments #7, #20 and #35 together, show that for a different sol-
vent but with similar flow rates of both phases, the resulting powder is
different. Indeed, in the first mentioned set, an organic solution flow
rate of 1.9 mL min−1 and a CO2 flow rate of 21 g min−1 are applied.
When acetone is used (#4), a polymorphic mixture is obtained, whereas
when acetonitrile (#19) or tetrahydrofuran (#34) are used, a pure form
IV powder is obtained. In the second mentioned set, the organic solu-
tion flow rate was set at 1.9 mL min−1 and the CO2 flow rate was set at
10 g min−1. In this case, when the organic solvent is acetone (#7), the
obtained powder is 100% form IV, while a mixture of both was obtained
when acetonitrile (#20) or tetrahydrofuran (#35) are used.
The initial concentration of STZ in the organic solution also has an
influence on the polymorphic behavior as it has a direct connection
with overall supersaturation. Experiments #18 and #19, using acet-
onitrile as solvent, show a shift in the polymorphic form of resulting
powders from pure form IV to pure form I induced by an increased STZ
concentration in the organic solution form β = 0.6 to β = 0.7. This
induces a higher supersaturation, thus a faster nucleation and growth
rate, at constant Xsolv/CO2. Weber Brun et al. [38] have reported a
contradictory behavior in the case of caffeine crystallized with SAS. A
higher proportion of the stable form (at ambient condition of pressure
and temperature) has been observed at high initial concentration of
solute. However, the proportion of crystalline material (crystalline
versus amorphous) decreases by increasing initial concentration of
Fig. 5. SEM observations and PSD of form IV of sulfathiazole, obtained with exp. #7 (acetone), exp. #19 (acetonitrile) and exp. #34 (tetrahydrofuran).
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solute. In the case of a solute exhibiting more than one polymorphic
form, the obtained form is not only control by the initial concentration
of solute but can depend on a variety of process parameters.
Repeatability was measured for some experiments. Two reproduced
experiments are given in Table 4, namely #4′ and #4′′ repeating ex-
periments #4, and #12′ repeating experiment #12. In every case, when
either a mixture or a pure form is obtained, the repeatability is verified.
3.3. SEM observations
Crystalline powders from experiments #3, #7, #18, #19, #31, #34
and #41 (Table 3), pure in one polymorphic form, were observed with
SEM. Their habits are presented in SEM photographs for forms IV and I
in Fig. 5 and Fig. 6, respectively.
A wide variation of crystals habit can be shown for the form IV of
STZ (Fig. 5). When reprocessed by SAS from pure acetone (#7), STZ
crystals exhibit large and extremely thin plate- or leaf-like habit. The
particle size distribution (PSD) shows two peaks, one around 3 μm and
the other around 20 μm. This distribution is classical in the case of
fragile crystals. The smaller particles are the result of either attrition
during the crystallization/washing steps, leading to the formation of
spherical particles (diameter under or close to 1 μm), or mechanical
breaking of larger crystals, inside the reactor, during the collecting step
or during the SEM sample preparation. When acetonitrile was used as a
solvent (#19), crystal habit was equant. The obtained powder has a
narrow PSD, at around 2 μm. Lastly, when the solvent used was tetra-
hydrofuran (#34), crystal habit is of a plate-like type like that of
acetone. An important aggregation is however evidenced with the
formation of spherical clusters. This behavior prevents attrition and
breaking from occurring, the obtained powder therefore has a narrow
PSD.
From these pictures, two different crystallization mechanisms have
been identified:
(a) A nucleation and growth mechanism, leading to particles with a
crystal shape, such as those obtained in acetone (Fig. 5, #7) and
acetonitrile (Fig. 5, #19). This highlights a gas-like phase composed
of all the 3 components in a continuous, mixed phase. Crystal
growth occurs by the successive adhesion of crystal units that dif-
fuses through the bulk. In this liquid-like behavior, the growth rate
strongly depends on the probability of a crystal unit meeting a
grown crystal. Reducing the crystal size can therefore be achieved
by decreasing the solute concentration, for example.
(b) A droplet drying mechanism, leading to quasi-spherical particles
composed of aggregated nanocrystals, such as those obtained in
tetrahydrofuran (Fig. 5, #34). In this case, an interface still exists
between the CO2-rich phase and the organic solution droplet, im-
posing the spherical shape of generated particles. Crystallization
kinetics are therefore highly dependent on the double-diffusivity
effect, mostly affected by the affinity between solvent and CO2.
STZ crystals of form I (Fig. 6) exhibit two different crystal habits,
namely needle-like, and aggregated clusters of plate-like habits, corre-
sponding to the nucleation and growth mechanism and the droplet
drying mechanism, respectively. The latter is observable with all tested
solvent, while being mainly observed with acetone and acetonitrile (#3
and #18, respectively, 100% of observed particles), but also visible
with tetrahydrofuran (#31) and with acetic acid (#41). The nucleation
and growth mechanism is only observable when tetrahydrofuran and
acetic acid were used, both experimental conditions leading to needle-
like crystals. This habit clearly indicates that the growth rate of one or a
couple of faces has been slowed down. PSD for an observed sample with
Fig. 6. SEM observations and PSD of form I of sulfathiazole, obtained with exp. #3 (acetone), exp. #18 (acetonitrile), exp. #31 (tetrahydrofuran) and exp. #41 (acetic acid).
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both acetone and acetonitrile are narrow around 3 and 2 μm, respec-
tively. However, with both tetrahydrofuran and acetic acid, the PSD is
widely distributed. This is due to the combined presence of needle-like
crystals and spherical clusters. The smaller particles are observed in the
case of acetic acid used as a solvent.
This large habit disparity of crystal habits, for both polymorphic
forms IV and I, highlights how important the solvent is for controlling
crystal habit. The solvent acts as a growth inhibitor for a given set of
crystal faces by adsorbing differently at the surface of every crystal face.
The higher the solvent adsorption, the higher the drop of the surface
free energy, for a given crystal face. Moreover, it is well established that
the different surface free energy of each crystal’s face is habit-control-
ling, and can be modified by solvent adsorption [39]. Therefore, pre-
dicting the crystal habit can be performed by predicting the surface
energy as well as solvent adsorption energies thanks to molecular
modelling [40]. A current work consisting in the prediction of solvent
adsorption energies for STZ is ongoing to validate the method for
crystallization in a supercritical medium.
4. Conclusions
The polymorphic and habit control of sulfathiazole has been studied
from the supercritical antisolvent process and with different organic
solvents. At moderate mixing conditions and for low supersaturation
values, the form IV is obtained, whilst at intense mixing conditions, fast
nucleation kinetics lead to formation of form I. Furthermore, crystal
habit can be severely influenced by the solvent. Indeed, depending on
the solvent nature, polymorphic form IV crystals of sulfathiazole can
exhibit a thin plate-like habit or an equant habit. The same behavior
occurs for the polymorphic form I crystals of sulfathiazole, exhibiting
either a plate-like habit or a needle-like habit. More importantly, two
crystallization mechanisms have been identified and are affected by the
nature of solvent. These two mechanisms are liquid-like nucleation and
growth mechanism and droplet drying mechanism, and depend on
hydrodynamic conditions as well as on the affinity between organic
solvent and CO2. These two behaviors further point out how important
and complex the choice of a solvent is for particle generation with the
supercritical anti-solvent process.
The strong dependence of crystal habit on the solvent used, in the
case of nucleation and growth mechanism, can be imputed to the sol-
vent’s ability (or inability) to perform strong intermolecular interac-
tions with a given set of crystal faces. These intermolecular interactions
can be regarded as solvent molecules adsorbed at the surface of a
crystal, which may be the cause of the crystal habit changes. Adsorption
energies can be calculated through molecular modelling to predict and
control the crystal habit, for example in a drug producing perspective.
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